


<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>Dofollow Social Bookmarking Sites 2016 / nexusbioquest1 / Published News</title>
<link>http://www.development.dofollowlinks.org</link>
<description>Your Source for Social News and Networking</description>
<pubDate>Thu, 23 May 2024 12:25:13 +0000</pubDate>
<language>en</language>
<item>
	<title><![CDATA[NEXUS BIOQUEST LIMITED]]></title>
	<link>http://www.development.dofollowlinks.org/News/nexus-bioquest-limited/</link>
	<source url="http://www.development.dofollowlinks.org/News/nexus-bioquest-limited/"><![CDATA[NEXUS BIOQUEST LIMITED]]></source>
	<description><![CDATA[<br /><br /><br />Address:<br />9th Floor 107 Cheapside, London, Greater London EC2V 6DN, United Kingdom<br /><br />Telephone number:<br />01275 840029<br /><br />Business Email:<br />team@nexusbioquest.com<br />Description:<br />Nexus BioQuest is a specialized Contract Research Organization (CRO) operating in a laboratory setting, with a primary focus on Immuno-oncology, autoimmunity, Inflammation, and Neuro inflammation fields. Our organization offers expert knowledge in immunology and provides flexible research solutions to accelerate the development of immune-based therapies for clinical use. Leveraging our collective experience, Nexus BioQuest is committed to constructing a robust portfolio of immunology research, aimed at delivering innovative solutions for our clients' drug discovery initiatives. Whether you intend to harness the immune system for therapeutic purposes or target it for disease management, our team of dedicated immunologists eagerly anticipates the opportunity to collaborate with you. We are prepared to collaborate on the design and execution of experiments that will expedite your research goals.<br /><br />Keywords:<br />immunology cro, assays in drug discovery, Drug Discovery Preclinical CRO, Contract Research Organisation, Clinical Research Organisations, autoimmune cro, biochemical assays drug discovery<br /> ]]></description>
	<pubDate>Thu, 23 May 2024 12:25:13 +0000</pubDate>
	<author>nexusbioquest1</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.development.dofollowlinks.org/News/nexus-bioquest-limited/</guid>
</item>

</channel>
</rss>
